Successful completion of phase 1 multi-dose study
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Financial Update and Refund Of Rights Issue
- Appendix 3B
- UPDATE
- Positive trial results
- ArTiMist - CLINICAL TRIAL STATUS REPORT
Later from Arovella Therapeutics
- Anti-Malaria Treatment ArTiMist Enters Production
- ArTiMist trial update
- Commitments Test Entity - Third Quarter Report
- Eastland acquires Phoenix Medical Equipment Services
- Eastland`s fight againts Malaria bolstered
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics